Hartford Financial Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-30
| Closed | -$6.96K | – | 385 |
|
|
2024
Q2 | $6.96K | Buy |
+30
| New | +$6.52K | ﹤0.01% | 316 |
|
|
2024
Q1 | – | Sell |
-31
| Closed | -$8.02K | – | 383 |
|
|
2023
Q4 | $8.02K | Hold |
31
| – | – | ﹤0.01% | 321 |
|
|
2023
Q3 | $7.97K | Hold |
31
| – | – | ﹤0.01% | 313 |
|
|
2023
Q2 | $8.83K | Hold |
31
| – | – | ﹤0.01% | 292 |
|
|
2023
Q1 | $8.62K | Sell |
31
-35
| -53% | -$9.68K | ﹤0.01% | 290 |
|
|
2022
Q4 | $18.3K | Sell |
66
-45
| -41% | -$12.7K | ﹤0.01% | 249 |
|
|
2022
Q3 | $30K | Sell |
111
-4
| -3% | -$850 | 0.01% | 230 |
|
|
2022
Q2 | $23K | Hold |
115
| – | – | 0.01% | 240 |
|
|
2022
Q1 | $24K | Hold |
115
| – | – | 0.01% | 247 |
|
|
2021
Q4 | $28K | Hold |
115
| – | – | 0.01% | 242 |
|
|
2021
Q3 | $33K | Hold |
115
| – | – | 0.01% | 227 |
|
|
2021
Q2 | $40K | Hold |
115
| – | – | 0.01% | 221 |
|
|
2021
Q1 | $32K | Hold |
115
| – | – | 0.01% | 223 |
|
|
2020
Q4 | $28K | Hold |
115
| – | – | 0.01% | 230 |
|
|
2020
Q3 | $33K | Hold |
115
| – | – | 0.01% | 214 |
|
|
2020
Q2 | $31K | Hold |
115
| – | – | 0.01% | 219 |
|
|
2020
Q1 | $36K | Hold |
115
| – | – | 0.01% | 203 |
|
|
2019
Q4 | $34K | Hold |
115
| – | – | 0.01% | 231 |
|
|
2019
Q3 | $27K | Hold |
115
| – | – | 0.01% | 243 |
|
|
2019
Q2 | $27K | Hold |
115
| – | – | 0.01% | 243 |
|
|
2019
Q1 | $27K | Hold |
115
| – | – | 0.01% | 241 |
|
|
2018
Q4 | $35K | Hold |
115
| – | – | 0.01% | 234 |
|
|
2018
Q3 | $41K | Hold |
115
| – | – | 0.01% | 239 |
|
|
2018
Q2 | $33K | Hold |
115
| – | – | 0.01% | 250 |
|
|
2018
Q1 | $31K | Hold |
115
| – | – | 0.02% | 197 |
|
|
2017
Q4 | $36K | Hold |
115
| – | – | 0.02% | 190 |
|
|
2017
Q3 | $36K | Hold |
115
| – | – | 0.02% | 206 |
|
|
2017
Q2 | $31K | Hold |
115
| – | – | 0.01% | 208 |
|
|
2017
Q1 | $31K | Buy |
+115
| New | +$32.5K | 0.02% | 200 |
|
|
2016
Q4 | – | Sell |
-115
| Closed | -$35K | – | 320 |
|
|
2016
Q3 | $35K | Hold |
115
| – | – | 0.02% | 174 |
|
|
2016
Q2 | $27K | Hold |
115
| – | – | 0.02% | 174 |
|
|
2016
Q1 | $29K | Buy |
+115
| New | +$30.4K | 0.02% | 169 |
|
Other funds holding BIIB
Hartford Financial Management's BIIB Position: Q3 2024 in Review
Hartford Financial Management sold out of Biogen (BIIB) in Q3 2024, closing a stake of 30 shares — an estimated $6.96K sold.
Hartford Financial Management first reported a position in BIIB in Q1 2016 and held it in 32 quarters. The position peaked at $41K in Q3 2018. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.
- Hartford Financial Management reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
- Hartford Financial Management sold 30 Biogen shares in Q3 2024, an estimated $6.96K.
- Hartford Financial Management first reported a position in Biogen in Q1 2016 and held it in 32 quarters.
- Hartford Financial Management's Biogen position peaked at $41K in Q3 2018.
- 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.
Based on Hartford Financial Management's 13F filing for Q3 2024, filed 28 Oct 2024.